These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6109012)

  • 41. [Effects of haloperidol on extracellular contents of dopamine and its metabolites in the septum of rats during interspecies aggression].
    Gaĭnetdinov RR; Gromov AI; Kudrin VS; Pletnikov MS
    Biull Eksp Biol Med; 1992 Sep; 114(9):231-3. PubMed ID: 1477338
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Changes in brain volume in response to estradiol levels, amphetamine sensitization and haloperidol treatment in awake female rats.
    Madularu D; Kulkarni P; Ferris CF; Brake WG
    Brain Res; 2015 Aug; 1618():100-10. PubMed ID: 26032742
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Brain tyrosine depletion attenuates haloperidol-induced striatal dopamine release in vivo and augments haloperidol-induced catalepsy in the rat.
    Jaskiw GE; Bongiovanni R
    Psychopharmacology (Berl); 2004 Feb; 172(1):100-7. PubMed ID: 14586541
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of systemically administered caerulein on dopamine metabolism in rat brain.
    Matsumoto T; Nakahara T; Uchimura H; Hirano M; Yokoo H; Nakamura K; Oomagari K
    Brain Res; 1984 Dec; 324(1):195-9. PubMed ID: 6518389
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of (+-)3,4-methylenedioxymethamphetamine (MDMA) on brain dopaminergic activity in rats.
    Matthews RT; Champney TH; Frye GD
    Pharmacol Biochem Behav; 1989 Aug; 33(4):741-7. PubMed ID: 2575758
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A dopaminergic mechanism is involved in the 'anxiogenic-like' response induced by chronic amphetamine treatment: a behavioral and neurochemical study.
    Cancela LM; Basso AM; Martijena ID; Capriles NR; Molina VA
    Brain Res; 2001 Aug; 909(1-2):179-86. PubMed ID: 11478934
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Maintenance of amphetamine-induced stereotypy and locomotion requires ongoing dopamine receptor activation.
    Conti LH; Segal DS; Kuczenski R
    Psychopharmacology (Berl); 1997 Mar; 130(2):183-8. PubMed ID: 9106917
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dual effects of nicotine on neuroleptic-induced changes of striatal dopamine metabolism in mice.
    Haikala H
    Pharmacol Toxicol; 1989 Apr; 64(4):334-9. PubMed ID: 2568630
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activation of striatal dopaminergic grafts by haloperidol.
    Herman JP; Choulli K; Le Moal M
    Brain Res Bull; 1985 Dec; 15(6):543-6. PubMed ID: 3936594
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clorgyline-induced increases in presynaptic DA: changes in the behavioral and neurochemical effects of amphetamine using in vivo microdialysis.
    Segal DS; Kuczenski R; Okuda C
    Pharmacol Biochem Behav; 1992 Jul; 42(3):421-9. PubMed ID: 1409775
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of mecamylamine on the fate of dopamine in striatal and mesolimbic areas of rat brain; interaction with morphine and haloperidol.
    Ahtee L; Kaakkola S
    Br J Pharmacol; 1978 Feb; 62(2):213-8. PubMed ID: 564219
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Microdialysis studies of D-amphetamine-evoked striatal dopamine overflow in young versus aged F344 rats: effects of concentration and order of administration.
    Purdom MS; Stanford JA; Currier TD; Gerhardt GA
    Brain Res; 2003 Jul; 979(1-2):203-9. PubMed ID: 12850587
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Amphetamine-haloperidol interactions in rat striatum: failure to correlate behavioral effects with dopaminergic and cholinergic dynamics.
    Kuczenski R; Schmidt D; Leith N
    Brain Res; 1977 Apr; 126(1):117-29. PubMed ID: 558038
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Comparative effect of the psychostimulants sidnocarb and fenamin on the tyrosine hydroxylase activity of the brain synaptosomes in rats].
    Ganiev MM; Kudrin VS; Raevskiĭ KS
    Farmakol Toksikol; 1985; 48(2):27-32. PubMed ID: 2860009
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis.
    Robinson TE; Becker JB
    Brain Res; 1986 Jun; 396(2):157-98. PubMed ID: 3527341
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mesolimbic dopamine turnover effects of benzodiazepines do not correlate with sedative and muscle-relaxant potencies.
    van der Laan JW; Eigeman L; van 't Land CJ
    Arch Int Pharmacodyn Ther; 1993; 326():13-21. PubMed ID: 8185409
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Haloperidol: effect of long-term treatment on rat striatal dopamine synthesis and turnover.
    Lerner P; Nosé P; Gordon EK; Lovenberg W
    Science; 1977 Jul; 197(4299):181-3. PubMed ID: 17917
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interaction of haloperidol and gamma-butyrolactone with (+)-amphetamine-induced changes in monoamine synthesis and metabolism in rat brain.
    Kehr W; Speckenbach W; Zimmermann R
    J Neural Transm; 1977; 40(2):129-47. PubMed ID: 323421
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 8-OH-DPAT, a 5-HT1A agonist and ritanserin, a 5-HT2A/C antagonist, reverse haloperidol-induced catalepsy in rats independently of striatal dopamine release.
    Lucas G; Bonhomme N; De Deurwaerdère P; Le Moal M; Spampinato U
    Psychopharmacology (Berl); 1997 May; 131(1):57-63. PubMed ID: 9181636
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interaction between chronic amphetamine and neuroleptic treatments on oral behavior in rats.
    Levy AD; Ellison GD
    Psychopharmacology (Berl); 1987; 93(2):218-22. PubMed ID: 3122254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.